326
T. Lomberget et al.
FEATURE ARTICLE
IR (KBr): 2950, 2930, 2840, 2240, 1760, 1720, 1635, 1605, 1440,
1405, 1310, 1280, 1250, 1180, 1110, 1040, 1015, 980, 950, 935,
905, 875, 850, 785, 750, 710, 690 cm–1.
1H NMR (300 MHz, CDCl3): d = 1.94 (quint, J = 6.1 Hz, 2 H), 2.18
(m, 1 H), 2.37–2.51 (m, 2 H), 2.63 (dt, J = 13.6, 5.2 Hz, 1 H), 3.86
(s, 3 H), 3.91 (s, 3 H), 4.76 (s, 1 H), 5.02 (d, J = 1.5 Hz, 1 H), 6.67
(s, 1 H), 7.39 (d, J = 8.3 Hz, 2 H), 7.94 (d, J = 8.3 Hz, 2 H).
13C NMR (75 MHz, CDCl3): d = 23.8, 35.7, 35.8, 52.5, 53.5, 54.2,
118.1, 118.3, 127.6, 129.3, 129.3, 129.8, 138.3, 140.9, 141.1, 167.1,
167.2.
CI-HRMS calcd for C21H24O6: 373.1651 (MH+), found 373.1652.
3-Methylene-2-{2-[(tetrahydropyran-2-yloxy)methyl]ben-
zylidene}cyclohexane-1,1-dicarboxylic Acid Dimethyl Ester
(19b)
According to GP1, scale: KH (48 mg, 1.2 mmol), 18-C-6 (53 mg,
0.2 mmol), enyne 2b (224 mg, 1.0 mmol), iodide 9b (477 mg, 1.5
mmol), PdCl2(PPh3)2 (35 mg, 0.05 mmol), THF (10 mL). After pu-
rification (PE–Et2O, 80:20), the cyclization product 19b was ob-
tained as a white solid. Yield: 216 mg (52%); mp 67–69 °C.
IR (KBr): 2949, 2869, 1744, 1727, 1636, 1446, 1436, 1268, 1245,
1120, 1059, 1028, 979, 902 cm–1.
1H NMR (300 MHz, CDCl3): d = 1.56–1.85 (br m, 8 H), 2.35 (br t,
J = 6.1 Hz, 2 H), 2.40 (br t, J = 6.1 Hz, 2 H), 3.54 (m, 1 H), 3.77 (s,
6 H), 3.91 (m, 1 H), 4.49 (m, 2 H), 4.73 (m, 2 H), 4.78 (d, J = 1.9
Hz, 1 H), 6.32 (s, 1 H), 7.14–7.19 (m, 3 H), 7.37 (d, J = 6.4 Hz, 1 H).
13C NMR (75 MHz, CDCl3): d = 19.4, 24.0, 25.6, 30.6, 33.7, 36.2,
52.7, 62.0, 64.6, 67.3, 98.1, 116.6, 125.8, 126.9, 127.3, 128.4,
129.2, 136.2, 137.0, 140.2, 142.7, 170.9.
Anal. Calcd for C19H19NO4 (325.36): C, 70.14; H, 5.89; N, 4.31.
Found: C, 70.07; H, 5.92; N, 4.36.
(E)-1-Cyano-3-methylene-2-(3-trifluoromethylbenzylidene)cy-
clohexanecarboxylic Acid Methyl Ester (14a)
According to GP1, scale: KH (48 mg, 1.2 mmol), 18-C-6 (53 mg,
0.2 mmol), enyne 2a (191 mg, 1.0 mmol), m-trifluoromethyliodo-
benzene (220 mL, 1.5 mmol), PdCl2(PPh3)2 (35 mg, 0.05 mmol),
THF (10 mL) at 50 °C. After purification (PE–Et2O, 80:20), two
products were isolated: the less polar fraction corresponds to the cy-
clization product 14a which was obtained as a colorless oil. Yield:
153 mg (46%).
Anal. Calcd for C24H30O6 (414,49): C, 69.54; H, 7.30. Found: C,
69.63; H, 7.49.
IR (film): 3080, 2940, 2860, 2840, 2230, 1750, 1635, 1590, 1485,
1435, 1330, 1280, 1230, 1210, 1160, 1120, 1090, 1030, 985, 905,
875, 700 cm–1.
1H NMR (300 MHz, CDCl3): d = 1.92 (quint, J = 5.9 Hz, 2 H), 2.17
(m, 1 H), 2.36–2.50 (m, 2 H), 2.60 (dt, J = 13.6, 5.2 Hz, 1 H), 3.85
(s, 3 H), 4.76 (d, J = 1.5 Hz, 1 H), 5.02 (dd, J = 1.5, 1.5 Hz, 1 H),
6.66 (s, 1 H), 7.37 (t, J = 7.4 Hz, 1 H), 7.45 (d, J = 7.4 Hz, 1 H), 7.50
(d, J = 7.4 Hz, 1 H), 7.58 (s, 1 H).
(E)-1-Cyano-3-methylene-2-(3-phenylprop-2-enylidene)cyclo-
hexanecarboxylic Acid Methyl Ester (20a)
According to GP1, scale: KH (48 mg, 1.2 mmol), 18-C-6 (53 mg,
0.2 mmol), enyne 2a (191 mg, 1.0 mmol), b-bromostyrene (260 mL,
2.0 mmol, 85:15 trans:cis mixture), PdCl2(PPh3)2 (35 mg, 0.05
mmol), THF (10 mL). After purification (PE–Et2O, 80:20), the cy-
clization product 20a was obtained as a pale yellow solid. Yield:
209 mg (71%); mp 73–75 °C.
IR (neat): 3070, 3020, 2950, 2930, 2860, 2840, 2230, 1750, 1625,
1590, 1490, 1440, 1250, 1190, 1160, 1075, 1035, 975, 910, 835,
745, 645 cm–1.
1H NMR (300 MHz, CDCl3): d = 1.90 (quint, J = 6.1 Hz, 2 H), 2.12
(dt, J = 12.8, 7.4 Hz, 1 H), 2.24–2.41 (m, 2 H), 2.56 (dt, J = 13.6,
5.0 Hz, 1 H), 3.85 (s, 3 H), 5.04 (s, 1 H), 5.30 (s, 1 H), 6.48 (d,
J = 10.7 Hz, 1 H), 6.74 (d, J = 15.5 Hz, 1 H), 7.12 (dd, J = 15.5,
10.7 Hz, 1 H), 7.32 (m, 5 H).
13C NMR (50 MHz, CDCl3): d = 23.4, 35.4, 35.4, 53.0, 53.8, 117.7,
117.9, 124.0 (q, J = 272 Hz), 124.1 (q, J = 3.8 Hz), 125.8 (q, J = 3.8
Hz), 126.7, 128.6, 130.6 (q, J = 32.2 Hz), 132.2, 136.6, 137.8, 1408,
166.8.
Anal. Calcd for C18H16F3NO2 (335.32): C, 64.47; H, 4.81; N, 4.18.
Found: C, 64.70; H, 4.84; N, 4.17.
The more polar fraction is the corresponding direct coupling prod-
uct, which was obtained as a colorless oil. Yield: 45 mg (13%).
13C NMR (75 MHz, CDCl3): d = 23.1, 35.1, 35.3, 52.5, 53.7, 117.5,
118.1, 124.9, 126.7, 128.1, 128.7, 128.8, 135.0, 135.8, 137.1, 141.6,
167.3.
2-Cyano-6-methylene-8-(3-trifluoromethylphenyl)oct-7-ynoic
Acid Methyl Ester
1H NMR (300 MHz, CDCl3): 1.83 (m, 2 H), 2.01 (m, 2 H), 2.33 (t,
J = 7.0 Hz, 2 H), 3.57 (t, J = 6.8 Hz, 1 H), 3.81 (s, 3 H), 5.39 (dd,
J = 1.5, 1.5 Hz, 1 H), 5.51 (d, J = 1.5 Hz, 1 H), 7.44 (t, J = 7.4 Hz,
1 H), 7.56 (d, J = 7.5 Hz, 1 H), 7.62 (d, J = 7.4 Hz, 1 H), 7.71 (s, 1
H).
Anal. Calcd for C19H19NO2 (293.36): C, 77.79; H, 6.53; N, 4.77.
Found: C, 78.13; H, 6.46; N, 4.87.
(E)-1-Cyano-3-methylene-2-(3-phenylprop-2-enylidene)cyclo-
hexanecarboxylic Acid Isopropyl Ester (20g)
According to GP1, scale: KH (48 mg, 1.2 mmol), 18-C-6 (53 mg,
0.2 mmol), enyne 2g (221 mg, 1.0 mmol), b-bromostyrene (260 mL,
2.0 mmol, 85:15 trans:cis mixture), PdCl2(PPh3)2 (35 mg, 0.05
mmol), THF (10 mL). After purification (PE–Et2O, 80:20), the cy-
clization product 20g was obtained as a pale yellow solid. Yield:
224 mg (70%); mp 69–71 °C.
2-(4-Acetoxymethylbenzylidene)-3-methylenecyclohexane-1,1-
dicarboxylic Acid Dimethyl Ester (18b)
According to GP1, scale: KH (34 mg, 0.84 mmol), 18-C-6 (37 mg,
0.14 mmol), enyne 2b (156 mg, 0.7 mmol), iodide 9a (290 mg, 1.05
mmol), PdCl2(PPh3)2 (25 mg, 0.035 mmol), THF (7 mL). After pu-
rification (PE–Et2O, 60:40), the cyclization product 18b was ob-
tained as a solid. Yield: 123 mg (47%); mp 86–88 °C.
IR (KBr): 3040, 2980, 2927, 2870, 2247, 1750, 1738, 1634, 1592,
1447, 1386, 1231, 1181, 1107, 945, 885, 745, 639 cm–1.
IR (KBr): 2954, 1745, 1722, 1648, 1450, 1435, 1384, 1251, 1193,
1082, 1030, 922, 758 cm–1.
1H NMR (300 MHz, CDCl3): d = 1.70 (m, 2 H), 2.12 (s, 3 H), 2.35
(br t, J = 6.2 Hz, 2 H), 2.42 (br t, J = 6.1 Hz, 2 H), 3.78 (s, 6 H), 4.55
(d, J = 1.8 Hz, 1 H), 4.82 (s, 1 H), 5.11 (s, 2 H), 6.28 (s, 1 H), 7.22
(m, 3 H), 7.33 (m, 1 H).
1H NMR (300 MHz, CDCl3): d = 1.29 (d, J = 6.5 Hz, 3 H), 1.32 (d,
J = 6.5 Hz, 3 H), 1.88 (m, 2 H), 2.09 (m, 1 H), 2.25–2.41 (m, 4 H),
2.56 (dt, J = 13.2, 5.2 Hz, 1 H), 5.02 (s, 1 H), 5.11 (hept, J = 6.5 Hz,
1 H), 5.29 (s, 1 H), 6.53 (d, J = 10.7 Hz, 1 H), 6.73 (d, J = 15.8 Hz,
1 H), 7.13 (dd, J = 15.8, 10.7 Hz, 1 H), 7.32 (m, 1 H), 7.39 (t, J = 7.4
Hz, 2 H), 7.40 (m, 2 H).
13C NMR (75 MHz, CDCl3): d = 21.1, 24.0, 33.7, 34.3, 36.2, 52.8,
64.8, 116.9, 125.2, 127.2, 128.2, 129.0, 129.6, 132.6, 133.2, 140.8,
142.6, 169.4, 170.9.
13C NMR (50 MHz, CDCl3): d = 21.5, 21.6, 23.2, 35.1, 35.15, 52.5,
71.0, 117.3, 118.3, 125.0, 126.7, 128.0, 128.7, 128.7, 135.3, 135.5,
137.1, 141.8, 166.2.
Synthesis 2005, No. 2, 311–329 © Thieme Stuttgart · New York